Could ADHD medications trigger a positive result on roadside drug tests? This question has become increasingly relevant as roadside drug testing has surged in popularity since its inception in 2004, aiming to crack down on drivers under the influence of illegal substances.
Unlike alcohol testing, which quantifies blood alcohol levels to assess impairment, roadside drug testing simply detects the presence of any drugs in a person's system, irrespective of quantity or impact on driving ability. This practice has sparked significant backlash from drivers, particularly regarding the detection of THC from medicinal cannabis, as highlighted in a previous article on Drive. A reader pointed out, "The presence of THC doesn’t equate to impairment; it can remain in the body long after its effects have faded. The laws are lagging behind reality."
Another commenter echoed this sentiment: "Just because a substance is detected does not mean a driver is impaired."
However, the discussion took a turn when users highlighted concerns about ADHD medications, specifically lisdexamfetamine (commonly known as Vyvanse or Elvanse) and dexamphetamine, possibly yielding false positives for methamphetamine during roadside drug tests. One user mused, "Imagine the irony of someone being on ADHD medication but testing positive for meth! This is a genuine concern for those who depend on these prescriptions."
As of 2025, Vyvanse has become the most rapidly prescribed medication within Australia’s Pharmaceutical Benefits Scheme, surpassing even Ozempic, with the Federal Health Department reporting an increase of over 650,000 prescriptions issued that year. But what is the truth regarding the potential for these medications to show up positively on roadside drug tests?
Are dexamphetamine and methamphetamine detectable on roadside drug tests? While these two substances share similarities in their chemical makeup, they possess distinct markers that differentiate them. Nevertheless, a publication from Drug and Alcohol Research and Training Australia noted that individuals prescribed dexamphetamine have indeed tested positive in initial roadside screenings.
The article clarifies, "Typically, taking dexamphetamine alone shouldn’t yield a positive result on the initial roadside test. The two drugs aren't identical, so the initial screening shouldn't flag dexamphetamine." However, it also recounts experiences of young individuals who claimed to have tested positive for methamphetamine despite never using the drug, highlighting that they all passed follow-up lab tests.
These subsequent tests tend to be more precise, meaning that while a roadside test may indicate a false positive for methamphetamine, the lab results should clarify any misunderstandings. "If you take ADHD medication and get a positive result on a roadside drug test for methamphetamine, don't panic. You’ll need to undergo a more accurate secondary test, which should clear up any confusion stemming from your prescription," the article advises.
That said, if both the initial and follow-up tests return positive results before the lab analysis, the driver will face an immediate 24-hour driving ban—a major inconvenience for many.
It's essential to note that while there are no outright prohibitions against driving with a prescription for dexamphetamine or lisdexamfetamine, it is crucial to understand how these medications affect your body before operating a vehicle or machinery. Furthermore, if a driver exhibits erratic behavior, police can request a comprehensive blood test, and as stated by JBP Law, "taking over-the-counter medications that impair driving can lead to charges akin to driving under the influence of drugs."
In conclusion, the intersection of ADHD medication and roadside drug testing raises important questions about fairness and accuracy in drug testing practices. How do you perceive the current testing policies? Are they fair to individuals managing ADHD, or do they require reevaluation? Let's discuss!
